M&A activity is off to a strong start in 2026. While several large transactions are drawing attention, we are focusing on a move that could carry long-term implications for the spine market: VB Spine’s agreement to acquire the rights to the xvision Spine System from Augmedics.
This is not a routine tuck-in acquisition. It reflects a deliberate strategy aimed at addressing structural challenges that have historically limited growth in spine.
Before looking at the data, a quick refresher on the two companies involved.
VB Spine is currently the largest privately held spine company, despite being less than one year old (at the time of this article’s publication). The company was formed in April 2025 when the Viscogliosi Brothers acquired Stryker’s U.S. spinal implants business, excluding MAKO and Copilot. That transaction immediately created a major player with a broad portfolio, expanding global distribution, and a surgeon-focused approach.
Augmedics built its business around augmented reality in the operating room. Its core concept is straightforward: allow surgeons to visualize anatomy in 3D without diverting their attention away from the operative field. The company’s lead product, the xvision Spine System, has been used in more than 10,000 patient cases across the United States.
VB Spine has entered into a definitive agreement to acquire the rights to the xvision Spine System.
Now, let’s examine the broader context.
The global spine market is valued at approximately $12 billion. Growth, however, has lagged behind other orthopedic segments. From 2025 through 2030, spine device sales are projected to grow at a 3.9% CAGR. Over the same period, joint replacement implants are expected to grow at 4.3% CAGR, and the broader orthopedics market at 4.2% CAGR.
Several dynamics explain the slower trajectory.
Spine procedures are highly complex, and outcomes can vary based on surgeon technique. Reimbursement pressure remains a constraint, particularly in high-volume procedures such as lumbar fusion. In addition, spine has been slower than other orthopedic specialties to transition into outpatient settings.
Against that backdrop, VB Spine’s move is notable. Rather than acquiring in a faster-growing niche, the company is investing in a platform that directly targets long-standing friction points.
Spinal anatomy is highly variable, and the margin for error is small. The xvision Spine System is designed to improve visualization and navigation during surgery.
For surgeons, the system projects real-time 3D guidance directly into the operative field. Optical tracking shows instrument position relative to anatomy without requiring the surgeon to look away at a separate monitor. Its CT-Fluoro registration enables navigation using preoperative CT scans and standard 2D C-arm fluoroscopy, significantly reducing intraoperative radiation exposure for both the surgical team and the patient.
The facility impact is equally important. More than half of U.S. hospitals do not have access to 3D intraoperative imaging systems that many complex spine cases have traditionally required. This creates both cost and utilization barriers. By allowing navigation with equipment already available in most hospitals and ASCs, xvision expands access to advanced guidance capabilities.
Patients are the ultimate beneficiaries. In addition to reduced radiation exposure, accurate device placement is critical in spine procedures. Pedicle screw misplacement is among the most serious technical errors and can result in permanent neurological damage. Multiple clinical studies have reported 97–100% pedicle screw placement accuracy using xvision.
The clinical data, combined with broader facility access, positions the technology as a potential driver of adoption and loyalty.
Augmedics demonstrated meaningful commercial progress prior to this transaction. The company moved from its first commercial case in 2020 to approximately $8 million in revenue by 2024, according to Canaccord Genuity. Its CT-Fluoro registration technology doubled its addressable spine market and expanded its inpatient hospital reach from roughly 700 facilities to 2,000.
Commercial validation continues to be a major driver of medtech M&A activity.
Importantly, VB Spine acquired the rights to the xvision Spine System only. This allows Augmedics to focus on expanding its augmented reality expertise into adjacent surgical specialties.
At LSI USA ’25, John Viscogliosi spoke about improving visualization and making surgery more effective and less disruptive. Less than a year later, this acquisition aligns with those objectives.
More than 10 million spine procedures are performed annually. VB Spine is positioning itself to capture and expand that opportunity. For innovators operating in the spine market, a new long-term ecosystem builder has entered the field.
17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2026 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy